TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets.

PLoS One · 2020 · PMC7266295 · PMID 32484822

Europe PMC DOI

hedged sentence

0.1020

closest p · 2.0× alpha

0.1020

boldest claim

The sentences

did not reach statistical significancep = 0.102not close (p > 0.1)

Of note, the proportion of TRPM4 hi patients with worse stage (IIb-IV; 54.2%) was higher than with lower stage (I-IIa; 44.6%) albeit it did not reach statistical significance ( p = 0.102).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.